Kasiani C. Myers, MD

Loading...

Member, Division of Bone Marrow Transplantation and Immune Deficiency
Professor, UC Department of Pediatrics

kasiani.myers@cchmc.org
Board Certified

Burnet Campus

Make An Appointment

Existing PatientsMyChart Scheduling

AppointmentsCall Us to ScheduleAppointments1-513-636-3200

About

Biography

I always wanted to be a physician, and specifically a pediatrician. My father is an adult subspecialist, but I was drawn to the care of medically complex children. Now, I enjoy being the bridge between basic research and the clinic.

In my clinical practice, I specialize in treating patients with bone marrow failure and hematopoietic stem cell transplant for non-malignant diseases, with a special emphasis on Shwachman Diamond syndrome and dyskeratosis congenita. My research interests focus on translational and clinical studies in leukemogenesis and bone marrow failure related to these two conditions. I also study the complications of stem cell transplants, including bronchiolitis obliterans and fertility preservation.

I decided to pursue my research interests after my experience as a resident physician and fellow at Cincinnati Children’s. I enjoyed getting to know my patients on the bone marrow transplant and hematology/oncology units. Plus, I was mentored by two of the world’s foremost experts in the field, Dr. Stella Davies and Dr. Richard Harris, right here at Cincinnati Children’s.

After I completed my postdoctoral training, I joined the faculty of the Division of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children’s within the UC Department of Pediatrics. Now, in addition to clinical work and research, I serve as the co-director of the North American Shwachman Diamond Syndrome Registry.

Services and Specialties

Research Areas

Additional Languages

French, Greek

Location

Burnet Campus

3333 Burnet Ave
Cincinnati, OH 45229

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

G-CSF resistance of ELANE-mutant neutropenia depends on SERF1-containing truncated-neutrophil elastase aggregates. Nayak, RC; Emberesh, S; Trump, LR; Wellendorf, AM; Singh, AK; Korkmaz, B; Horwitz, MS; Myers, KC; Kalfa, TA; Lutzko, CM; Cancelas, JA. The Journal of Clinical Investigation. 2025; 135:e177342.

Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia. Voit, RA; Liao, X; Caulier, A; Antoszewski, M; Cohen, B; Armant, M; Lu, HY; Fleming, TJ; Kamal, E; Wahlster, L; Pellin, D; Shimamura, A; Williams, DA; Sankaran, VG. Cell Stem Cell. 2025; 32:38-52.e6.

Outcomes of Hematopoietic Stem Cell Transplantation for High-Risk Marrow Features without Malignancy in Shwachman-Diamond Syndrome. Andresen, F; He, J; Weller, E; Goldberg, B; Reilly, CR; Nakano, TA; Bertuch, AA; Geddis, AE; Joos, M; Coyne, K; Brundige, K; Loveless, S; Cheng, L; Myers, K; Shimamura, A. Blood. 2024; 144:441.

Incidence of Myeloid Malignancy in Shwachman-Diamond Syndrome: An International Cohort Study. Myers, K; He, J; Goldberg, B; Reilly, CR; Wan, Y; Zhu, X; Cesaro, S; Cipolli, M; Bertuch, AA; O'Farrell, C; Cheng, L; Weller, E; Donadieu, J; Shimamura, A. Blood. 2024; 144:2703.

GATA2-TGF-b1-TAL1 Axis Is Essential for Human NK Cell Development and Function. Wang, D; Zhang, F; Yang, C; George, A; Veltri, A; Thakar, M; Verbsky, J; Myers, K; Kee, BL; Rao, S; Bresnick, EH; Malarkannan, S. Blood. 2024; 144:5398.

Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. Lee, CJ; Hellewell, EM; Ng, K; Gooley, T; Sung, AD; Taylor, AO; Hong, S; Ahmed, N; Morey, C; Fitzmaurice, S; Yingling, S; Edgar, C; Browning, A; Bhatt, N. Blood. 2024; 144:2170.

Lymphoid Malignancies in Shwachman-Diamond Syndrome. Reed, HD; Do, H; Weller, EA; Harris, MH; Farrar, JE; Lau, BW; Pommert, L; Gamper, C; Atkinson, I; Coyne, K; Cheng, L; Malsch, M; Myers, K; Shimamura, A. Blood. 2024; 144:5707.

Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. Bhatt, NS; Hellewell, EM; Ng, K; Gooley, T; Sung, AD; Taylor, AO; Hong, S; Ahmed, N; Morey, C; Fitzmaurice, S; Yingling, S; Edgar, C; Browning, A; Lee, CJ. Blood. 2024; 144:4921.

Infrequent fractures and resilient bone mineral density: bone health in patients with Fanconi anemia. Koo, J; Howell, JC; Hornung, L; Sabulski, A; Mehta, PA; Davies, SM; Myers, KC. Haematologica: the hematology journal. 2024; 109:3435-3438.

Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study. Kahn, J; Brazauskas, R; Bo-Subait, S; Buchbinder, D; Hamilton, BK; Schoemans, H; Abraham, AA; Agrawal, V; Auletta, JJ; Badawy, SM; Williams, KM; Vrooman, LM; Satwani, P; Phelan, R. The Lancet Child and Adolescent Health. 2024; 8:740-750.

From the Blog

Cancer

First Gene Therapy Trial for Telomere Biology Disorders Shows Promising Results

Kasiani C. Myers, MD2/25/2025

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...